Journal
GROWTH HORMONE & IGF RESEARCH
Volume 18, Issue 1, Pages 65-74Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.ghir.2007.07.007
Keywords
acid-labile subunit; insulin-like growth factor-I; insulin-like growth factor binding protein; mouse insulin-like growth factor
Categories
Funding
- NCI NIH HHS [P50 CA 92131, 1 R01 CA 100938, R01 CA100938-05, R01 CA100938, P50 CA092131] Funding Source: Medline
- NIA NIH HHS [R01 AG020954-04, R01 AG020954, R01 AG018381, 2 R01 AG 018381] Funding Source: Medline
- NICHD NIH HHS [R01 HD047013-04, R01 HD047013, 1 R01 HD 047013] Funding Source: Medline
- NIDDK NIH HHS [P30 DK063491, P30 DK 063491] Funding Source: Medline
Ask authors/readers for more resources
Objective: The mouse serves as an important model for insulin-like (IGF)-related research. However, lack of homologous mouse assays has prevented studies of the normal ontology of the murine IGF system. Therefore, we developed and validated immunoaassays for murine IGF-I, IGFBP-3 and ALS and studied levels of these analytes in mice. Methods: Using commercially available reagents, we developed and validated specific enzyme-linked immunosorbent assays (ELISAs) for murine IGF-I IGFBP-3, and ALS. Levels of these analytes were measured in sera from CD-1 mice, male and female, sampled at 1, 2, 4, 8, 20 and 32 weeks of age. In addition, sera from pregnant and postpartum CD-1 mice were also studied. Results: Validation of specific ELISAs for murine IGF-I, IGFBP-3 and ALS are described; all 3 assays were highly sensitive, precise and accurate. As measured by our homologous ELISA, IGF-I levels (ng/mL, mean +/- SD) in male mice were relatively low at I week (53 8), rising sharply to peak at 8 weeks of age (636 48), and gradually declining thereafter, reaching 395 64 at 32 weeks. IGF-I levels in non-pregnant female mice peaked at 4 weeks of age (548 77) declined at 8 weeks (417 61), then recovered to plateau at 539 78 and 535 88 at 20 and 32 weeks, respectively. In male mice, trends in IGFBP-3 were similar to the patterns of IGF-I However, in non-pregnant female mice, the IGFBP-3 levels declined relatively slowly after peaking at 4-weeks of age, unlike IGF-I levels during this period. ALS levels followed the same pattern as IGF-I in both sexes. IGF-I to IGFBP-3 molar ratios (percent) were similar between sexes, rising continuously with age: similar to 30% at 1 week, 80% at 4 weeks, 135% at 32 weeks. IGF-I was reduced in 8 week old mice in mid-pregnancy (354 75 vs 417 61 in non-pregnant 8 week females), reaching a nadir in late-term (146 40), and only partially recovering in the postpartum period (239 ::L 23). IGFBP-3 was also lower in late-pregnancy (1245 100 vs 1925 439) and remained depressed postpartum. In contrast to IGF-I and IGFBP-3, ALS increased more than threefold in mid-pregnancy (12180 1641 vs 3741 910), followed by a 4-fold decrease in late-pregnancy (2964 489), recovering postpartum (6104 1178). Conclusions: We report the first ontological studies of IGF-I, IGFBP-3 and ALS in mice using newly-characterized sensitive, homologous immunoassays. Our results indicate that mice have a generally similar pattern in IGF-related axis components, with low levels early in life, increasing to peak during sexual maturation and declining thereafter. Significant gender differences in non-pregnant levels and dramatic changes during pregnancy were also found. Knowledge of the normal developmental changes in the murine IGF system and accurate tools for investigations of this system are a necessary foundation for research in this field. (c) 2007 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available